Which patient is going to benefit from surgical cytoreduction with intraperitoneal chemotherapy (for manifest peritoneal metastases)?

Data publikacji: 09 mar 2018

Zakres stron: 207 - 210

Otrzymano: 18 gru 2017

Przyjęty: 29 gru 2017

DOI: https://doi.org/10.1515/cipms-2017-0040

Słowa kluczowe

peritoneal neoplasms, hyperthermia, induced, stomach neoplasms, cytoreduction surgical procedures, induction chemotherapy, laparoscopy

© 2017 Sebastian Blaj et al., published by De Gruyter Open

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.